SHIFTBIO INC.

SHIFTBIO INC. is pioneering the next paradigm shift in drug delivery systems through its AI-driven Natural Drug Delivery Platform. This innovative platform enables precise payload delivery to…

AIBiotechnologyDrug DeliveryNanoparticlesPlatform TechnologyPrecision Medicineshiftbio.net

SHIFTBIO INC.

SHIFTBIO INC. is pioneering the next paradigm shift in drug delivery systems through its AI-driven Natural Drug Delivery Platform. This innovative platform enables precise payload delivery to…

AIBiotechnologyDrug DeliveryNanoparticlesPlatform TechnologyPrecision Medicineshiftbio.net

HQSeoul, KR

Team Size22

Open Jobs2

Total Funding-

Latest FundraiseUnknown

Join the Team

BD manager

On-SiteSeoul, KR

On-Site • Seoul, KR

Startup jobs. A lot of them.

Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.

52,000+

Startups

65,000+

Open Roles

1,500+

New This Week

Frontend Developer

Full-timeAustin, US

Full-time • Austin, US

Product Designer

Full-timeMunich, DE

Full-time • Munich, DE

AI Researcher

Full-timeNovi Sad, RS

Full-time • Novi Sad, RS

Product Designer

InternshipHaifa

Internship • Haifa

Machine Learning Engineer

ContractAmsterdam, NL

Contract • Amsterdam, NL

DevOps Engineer

Full-timeNiš, RS

Full-time • Niš, RS

SHIFTBIO is hiring a Business Development Manager to drive global partnership and licensing activities. Prior BD experience strongly preferred. Title and compensation will be calibrated to background and capability.

About SHIFTBIO

SHIFTBIO (SBI) is a next-generation drug delivery platform biotech advancing cell-derived nanoparticle (NNP) therapeutics. Our NNP approach is enabled by the proprietary NNP Trinity, which integrates surface engineering (NSM Scaffold), AI-driven design (NNP Design AI), and scalable manufacturing (NNP Manufacturing).

This approach powers two delivery platforms. I-NNP (Immuno-NNP) targets oncology, fibrotic and autoimmune indications. B-NNP (Brain-NNP) is a dual-targeting brain shuttle that separates BBB crossing from cell-type-selective parenchymal uptake.

Pipeline: SBI-101 (oncology, FDA Pre-IND complete), SBI-102 (inflammation, FDA Orphan Drug Designation granted).

Co-founded by Prof. In-San Kim (MD/PhD) and CEO Gi-Hoon Nam (MD/PhD). We operate a US + Australia dual-region clinical entry strategy with a planned US subsidiary in the Boston/SF/Cambridge biotech hub.

The Role

Lead end-to-end deal execution from opportunity identification to term sheet. Activities include partner pipelining, CDA/MTA negotiation, term sheet development, due diligence support, competitive intelligence on EV/exosome and rare disease landscapes, and SHIFTBIO representation at international conferences.

Qualifications (Required)

Bachelor's in Life Sciences, Pharmacy, Chemistry, or related field
Prior BD experience in biotech, pharma, or healthcare investment
Working knowledge of drug development stages and regulatory pathways (FDA, EMA, PMDA, MFDS)
Commercial judgment in deal structuring (upfront, milestones, royalties, equity)
Business-level fluency in both English and Korean (essential for international deal execution)

Preferred

Master's, PhD, MBA, or PharmD
Direct experience in EV/exosome, gene therapy, RNA therapeutics, or DDS platforms
Prior deal closure experience (out-licensing, M&A, co-development)
Existing Big Pharma or VC network in US/EU/Japan
Japanese or Mandarin language ability

What We Offer

Base salary commensurate with experience plus performance-linked incentive
Stock options
Direct exposure to global Big Pharma BD counterparts and term sheet-level deal making
International conference attendance budget
Comprehensive medical insurance, statutory benefits, continuing education support
Onsite work at SHIFTBIO HQ (Seoul) with international travel

How to Apply

Send your CV and a brief cover note to bd@shiftbio.net. Please include "BD Manager Application - Your Name in the subject line.